Startseite High-Throughput Liquid Chromatography-Tandem Mass Spectrometric Analysis of Sirolimus in Whole Blood
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

High-Throughput Liquid Chromatography-Tandem Mass Spectrometric Analysis of Sirolimus in Whole Blood

  • Pierre E. Wallemacq , Roger Vanbinst , Stéphanie Asta und Donald P. Cooper
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 41 Heft 7

Abstract

Sirolimus appears as a new potent immunosuppressive agent taking advantage of therapeutic drug monitoring to optimize its use in organ transplantation. In the absence of any available commercial immunoassay it was mandatory to develop chromatographic assays. Some methods have already been proposed to quantify sirolimus in whole blood, based either on HPLC-UV, liquid chromatography-mass spectrometry (LC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). We have developed a new faster and simpler LC-MS/MS method to quantify sirolimus in blood using ascomycin as an internal standard and multiple reaction monitoring (MRM) acquisition mode. This method displays a limit of detection of 0.3 μg/l, and the intra-assay reproducibility ranges from 4.1–7.9%. The pre-analytical preparation steps are quite similar to those required for semi-automated immunoassays. Ascomycin and sirolimus present retention times of 0.89 and 0.93 min, respectively, and the turnaround time for a result (2.5 min) is also similar to that observed using a clinical analyzer. The comparison performed between HPLC-UV and LC-MS/MS displays good correlation (r = 0.949). The LC-MS/MS method described above has been used routinely for more than 2000 patient blood specimens and may present several advantages over existing methods, e.g., specificity with sufficient sensitivity, rapidity, and small blood sampling (10 μl), making it particularly adapted for routine clinical use.

:
Published Online: 2005-06-01
Published in Print: 2003-07-21

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. 18th ICCC 2002 Kyoto
  2. Essential Hypertension: Genes and Dreams
  3. Alteration of Nucleotide Metabolism: A New Mechanism for Mitochondrial Disorders
  4. Tryptophan Metabolites and Brain Disorders
  5. The Role of Interleukin-4 and Interleukin-13 in the Non-Immunologic Aspects of Asthma Pathogenesis
  6. Soluble Guanylyl Cyclase: Physiological Role as an NO Receptor and the Potential Molecular Target for Therapeutic Application
  7. The Increasing Impact of Laboratory Medicine on Clinical Cardiology
  8. Conveying the Importance of the Preanalytical Phase
  9. Polymorphisms in the IL-4 and IL-4R [α] Genes and Allergic Asthma
  10. Circulating Transforming Growth Factor-β1, Lipoprotein(a) and Cellular Adhesion Molecules in Angiographically Assessed Coronary Artery Disease
  11. Balance of Pro- and Anti-Inflammatory Cytokines in Liver Surgery
  12. Effect of Different Dialysis Membranes on Erythrocyte Antioxidant Enzyme Levels and Scavenger Systems Related to Free Hemoglobin in Serum of Hemodialysis Patients
  13. Fluorometric Assays of Phospholipase A2 Activity with Three Different Substrates in Biological Samples of Patients with Schizophrenia
  14. Determination of Itraconazole and Hydroxyitraconazole in Plasma by Use of Liquid Chromatography-Tandem Mass Spectrometry with On-line Solid-Phase Extraction
  15. High-Throughput Liquid Chromatography-Tandem Mass Spectrometric Analysis of Sirolimus in Whole Blood
  16. Prevention of Biochemical Changes in γ-Irradiated Rats by Some Metal Complexes
  17. Endocrine Alterations in the Aging Male
  18. Clinical Evaluation of Nine Free Thyroxine Assays: Persistent Problems in Particular Populations
  19. Immunoturbidimetric Determination of C-Reactive Protein (CRP) and High-Sensitivity CRP on Heparin Plasma. Comparison with Serum Determination
  20. Problems of Comparing Blood Glucose Molality and Molarity Determined with an Omni, an EML 105 and an Ebio Analyser
  21. Validation of an Automated Immunoturbidimetric Assay for Measurement of Plasma D-Dimer
  22. The Late Greco-Roman and Byzantine Contribution to the Evolution of Laboratory Examinations of Bodily Excrement. Part 1: Urine, Sperm, Menses and Stools
  23. Reference Interval for Lactate Dehydrogenase Catalytic Activity in Serum Measured According to the New IFCC Recommendations
  24. State-of-the-Art Systematic Error for Biochemical Quantities with Universal Cut-off Values or Universal Reference Limits
  25. Meetings and Awards
Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.140/html?lang=de
Button zum nach oben scrollen